Baseline computed tomography screening and blood microRNA predict lung cancer risk and define adequate intervals in the BioMILD trial期刊界 All Journals 搜尽天下杂志传播学术成果专业期刊搜索期刊信息化学术搜索

按检索

Baseline computed tomography screening and blood microRNA predict lung cancer risk and define adequate intervals in the BioMILD trial

Authors:	U Pastorino M Boeri S Sestini F Sabia G Milanese M Silva P Suatoni C Verri A Cantarutti N Sverzellati G Corrao A Marchianò G Sozzi

Institution:	1. Unit of Thoracic Surgery, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy;2. Tumour Genomics Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy;3. Section of Radiology, Unit of Surgical Sciences, Department of Medicine and Surgery (DiMeC), University of Parma, Parma, Italy;4. Division of Biostatistics, Department of Statistics and Quantitative Methods, Epidemiology and Public Health, University of Milano-Bicocca, Milan, Italy;5. Department of Radiology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan 20133, Italy

Abstract:

Keywords:	lung cancer screening low-dose computed tomography microRNA risk profile
本文献已被 ScienceDirect 等数据库收录！